Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Reviva Pharmaceuticals Hldg Inc
(NQ:
RVPH
)
2.900
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
70
Open
2.900
Bid (Size)
2.920 (1)
Ask (Size)
3.130 (10)
Prev. Close
2.900
Today's Range
2.900 - 2.900
52wk Range
2.670 - 9.250
Shares Outstanding
22,650,266
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
RVPH LOSS ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – RVPH
April 25, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm
April 25, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Performance
YTD
-45.39%
-45.39%
1 Month
-14.20%
-14.20%
3 Month
-29.78%
-29.78%
6 Month
-47.18%
-47.18%
1 Year
-60.92%
-60.92%
More News
Read More
RVPH Stock Earnings: Reviva Pharmaceuticals Misses EPS for Q4 2023
April 15, 2024
Via
InvestorPlace
Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs
January 23, 2024
Via
InvestorPlace
Expert Ratings for Reviva Pharmaceuticals
June 26, 2023
Via
Benzinga
Where Reviva Pharmaceuticals Stands With Analysts
June 08, 2023
Via
Benzinga
Reviva to Present at Webull LIVE! Healthcare Webinar on January 17
January 10, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 18, 2023
Via
Benzinga
Life Science Investor Forum: Presentations Now Available for Online Viewing
December 15, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Science Investor Forum Agenda Announced for December 14th, 2023
December 12, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum
December 11, 2023
From
Virtual Investor Conferences
Via
GlobeNewswire
Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock
October 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 30, 2023
Via
Benzinga
Could This Be A Breakthrough in Mental Health? Reviva's Schizophrenia Drug Shows Promising Results In Key Trial
October 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 27, 2023
Via
Benzinga
Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
September 29, 2023
Via
ACCESSWIRE
Reviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
September 22, 2023
Via
ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
September 20, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
August 17, 2023
Via
InvestorPlace
RedChip Launches 'Small Stocks, Big Money' Podcast
August 02, 2023
Via
ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2023
June 08, 2023
Via
Benzinga
Reviva Pharmaceuticals Holdings, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
April 19, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.